JPRN-UMIN000050051尚未招募Unknown
Systematic Review of the Effect of Intake of Beta-Nicotinamide Mononucleotide on Muscle Function - SR of the Effect of Intake of Beta-NMN on Muscle Function
Kino-Ken0 个研究点目标入组 10 人开始时间: 2023年1月20日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Other
入排标准
- 年龄范围
- 40years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Sick Person, Pregnant
研究者
相似试验
尚未招募
Unknown
Systematic Review of the Effect of Intake of Beta-Nicotinamide Mononucleotide on Skin FunctioJPRN-UMIN000051651Kino-Ken10
已完成
不适用
Study on effects of long-term ingestion of beta-cryptoxanthin-rich mandarin orange juice on body fat.obesityJPRN-UMIN000030820niversity of Nagasaki30
进行中（未招募）
1 期
A study to explore why certain types of inhaled medications cause an increased risk of worse outcomes among asthma patientsMedDRA version: 21.1Level: LLTClassification code 10003638Term: Atopic asthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersMedDRA version: 21.1Level: LLTClassification code 10001705Term: Allergic asthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersMedDRA version: 20.0Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersMedDRA version: 21.1Level: LLTClassification code 10003565Term: AsthmaticSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersMedDRA version: 21.1Level: LLTClassification code 10015575Term: Exacerbation of asthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersAsthmaEUCTR2019-003036-23-GBImperial College London24
进行中（未招募）
1 期
A Study exploring the Biologic Effects and Biomarkers of Nivolumab in combination with Ipilimumab in Subjects with Non-Small Cell Lung Cancer (NSCLC)EUCTR2018-000462-11-ESBristol-Myers Squibb International Corporation250
进行中（未招募）
1 期
A Study exploring the Biologic Effects and Biomarkers of Nivolumab in combination with Ipilimumab in Subjects with Non-Small Cell Lung Cancer (NSCLC)Treatment-Naive Stage IV or recurrent Non-Small Cell Lung Cancer (NSCLC)MedDRA version: 21.1Level: PTClassification code 10059515Term: Non-small cell lung cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.1Level: LLTClassification code 10080083Term: Advanced lung cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-000462-11-BEBristol-Myers Squibb International Corporation250